首页> 外文期刊>The annals of pharmacotherapy >Unusual Case of HIT With Cardiac Arrest During Hemodialysis
【24h】

Unusual Case of HIT With Cardiac Arrest During Hemodialysis

机译:血液透析期间发生心脏骤停的HIT异常病例

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To report an unusual case of heparin-induced thrombocytopenia (HIT) with cardiac arrest during hemodialysis (HD). Case Summary: An 88-year-old man previously treated with HD under enoxaparin for 3 years presented with dizziness and cyanosis at the beginning of HD on 3 consecutive sessions. Even though the dialyzer membrane was changed, he presented with cardiac arrest, from which he recovered quickly. At the same time, the platelet count fell, and HIT was suspected. No thrombosis was found. Anti-PF4/H, IL8, and NAP2 antibodies were negative, but platelet aggregation tests and serotonin-release assay were positive. After implementing HD with danaparoid, the platelet count returned to normal, and the patient remained asymptomatic. Discussion: Given the clinical context (low-molecular-weight heparin), complications (cardiac arrest and no thrombosis), and timing (3 years), this was an unusual case of HIT. According to the Naranjo probability scale, the causality of enoxaparin was evaluated as probable. In most reported cases, time to onset was short, clotting occurred in the extracorporeal system, and biological tests, including ELISA (enzyme-linked immunosorbent assay) anti-PF4/heparin, were positive. We found no triggering factor in this case, and given the biological results, a new antigenic target may be involved. Conclusions: HIT must be considered when acute systemic reactions occur at the beginning of HD sessions, even after several years of HD and with no change of anticoagulant, including low-molecular-weight heparin. The platelet count should be measured immediately after the reaction. The diagnosis is important because of possible cardiac arrest in this context.
机译:目的:报道一例罕见的肝素诱导的血小板减少症(HIT),并在血液透析(HD)期间出现心脏骤停。病例摘要:一位88岁的男性先前接受过依诺肝素3天的HD治疗,连续3次在HD开始时出现头晕和发cyan。即使透析器膜发生了变化,他仍表现出心脏骤停,并迅速康复。同时,血小板计数下降,怀疑是HIT。未发现血栓形成。抗PF4 / H,IL8和NAP2抗体均为阴性,但血小板凝集试验和血清素释放测定为阳性。用丹那普利实施HD后,血小板计数恢复正常,患者仍无症状。讨论:考虑到临床情况(低分子量肝素),并发症(心脏骤停且无血栓形成)和时机(3年),这是HIT的罕见病例。根据Naranjo概率量表,依诺肝素的因果关系被评估为可能。在大多数报道的病例中,发病时间很短,在体外系统中发生凝结,并且包括ELISA(酶联免疫吸附测定)抗PF4 /肝素在内的生物学测试均为阳性。在这种情况下,我们没有发现任何触发因素,并且鉴于生物学结果,可能涉及新的抗原靶标。结论:HD发作开始时,即使在HD发作数年后仍发生急性全身反应时,必须考虑HIT,且抗凝剂(包括低分子量肝素)无变化。反应后应立即测定血小板计数。诊断很重要,因为在这种情况下可能会导致心脏骤停。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号